期刊文献+

慢性肾脏病甲状旁腺激素水平与骨代谢指标的相关分析 被引量:3

Correlation Analysis between Parathyroid Hormone Levels and Bone Metabolism Indexes of Chronic Kidney Disease
下载PDF
导出
摘要 目的:分析慢性肾脏病(CKD)患者甲状旁腺激素(PTH)水平与骨代谢指标的关系。方法:搜集2014年1月-2016年6月于本院住院的164例CKD患者住院期间检测的PTH、骨代谢指标等临床数据,分析PTH水平与骨代谢指标的关系。结果:无论在透析患者或非透析患者中,随着PTH水平的升高,总I型胶原氨基酸(tPINP)、β-胶原特殊序列(β-CrossLaps)、骨钙素(Ost)、碱性磷酸酶(ALP)也随之升高,呈正相关,并且这种相关性较血钙、血磷与骨代谢指标的相关性更好,比较各个骨代谢指标的表达水平在不同PTH水平组间的差异有统计学意义。结论:在CKD患者中PTH水平与骨代谢关系密切,随着CKD患者PTH分泌水平的升高,骨代谢水平也随之活跃。 Objective:To analyze the relation between parathyroid hormone(PTH)levels and bone metabolism indexes of patients with chronic kidney disease(CKD).Methods:Clinical data such as PTH levels and bone metabolism indexes for 164 CKD patients hospitalized in our hospital from January 2014 to June 2016 were collected,and the relation between PTH levels and bone metabolism indexes was analyzed.Results:For both dialysis patients and non-dialysis patients,with the increase of PTH levels,the tPINP,β-CrossLaps,Ost,and ALP increased as well indicating positive correlation.And this correlation was better than the correlation between blood calcium,blood phosphorus and bone metabolism indexes.The comparison of expression levels of bone metabolism indexes between groups with different PTH levels was of statistical significance.Conclusion:The bone metabolism indexes of CKD patients are closely related to PTH level.With the increase of PTH level of CKD patients,the bone metabolism is active as well.
作者 黄兰婷 陈友明 郑晓艳 HUANG Lanting CHEN Youming ZHENG Xiaoyan(Department of Hematology, Fujian Provincial Hospital, Fuzhou City ,Fujian Province 350001)
出处 《医学理论与实践》 2017年第7期952-954,共3页 The Journal of Medical Theory and Practice
关键词 慢性肾脏病 甲状旁腺激素 骨代谢 相关分析 Chronic kidney disease Parathyroid hormone Bone metabolism Correlation analysis
  • 相关文献

参考文献3

二级参考文献25

  • 1邱明才,朱梅.如何正确理解骨质量[J].中华医学杂志,2005,85(11):723-724. 被引量:4
  • 2Pai AS,Giachelli CM.Matrix remodeling in vascular calcification associated with chronic kidney disease[J].J Am Soc Nephrol,2010,21(10):1637-1640. 被引量:1
  • 3Lieb W,Gona P,Larson MG,et al.Biomarkers of the osteoprotegerin pathway:clinical correlates,subclinical disease,incident cardiovascular disease,and mortality[J].Arterioscler Thromb Vasc Biol,2010,30(9):1849-1854. 被引量:1
  • 4National Kindney Foundation.K/DOQI clinical practice guidelines for chronic kidney disease:evaluation classification and stratification[J].Am J Kidney Dis,2002,39(2):S1-S266. 被引量:1
  • 5Hoek FJ,Kemperman FAW,Krediet RT.A comparison between cystatin C,plasma creatinine and Cockcroft and Gault formula for the estimation of glomerular filt ration rate[J].Nephrol Dial Transplant,2003,18(10):2024 -2031. 被引量:1
  • 6Van Campehout A,Golledge J.Osteoprotegerin,vascular calcification and atherosclerosis[J].Atherosclerosis,2009,204(2):321-329. 被引量:1
  • 7Valverde P,Tu Q,Chen J.BSP and RANKL induce genesis and bone resorption synergistically[J].J Bone Miner Res,2005,20(9):1669-1679. 被引量:1
  • 8Vik A,Mathiesen EB,Brox J,et al.Serum osteoprotegerin is a predictor for incident cardiovascular disease and mortality in a general population:The Troms Study[J].J Thromb Haemost,2011,9(4):638-644. 被引量:1
  • 9Kurnatowska I,Grzelak P,Kaczmarska M,et al.Serum osteoprotegerin is a predictor of progression of atherosclerosis and coronary calcification in hemodialysis patients[J].Nephron Clin Pract,2011,117(4):297-304. 被引量:1
  • 10Attman PO,Samuelsson O.Dyslipidemia of kidney disease[J].Curr Opin Lipidol,2009,20:293-299. 被引量:1

共引文献11

同被引文献39

引证文献3

二级引证文献133

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部